213 related articles for article (PubMed ID: 14678602)
1. Assessing human alloimmunization as a strategy for inducing HIV type 1 neutralizing anti-HLA responses.
Leith JG; Clark DA; Matthews TJ; Rosenthal KL; Luscher MA; Barber BH; MacDonald KS
AIDS Res Hum Retroviruses; 2003 Nov; 19(11):957-65. PubMed ID: 14678602
[TBL] [Abstract][Full Text] [Related]
2. Naturally occurring IgG anti-HLA alloantibody does not correlate with HIV type 1 resistance in Nairobi prostitutes.
Luscher MA; Choy G; Njagi E; Bwayo JJ; Anzala AO; Ndinya-Achola JO; Ball TB; Wade JA; Plummer FA; Barber BH; MacDonald KS
AIDS Res Hum Retroviruses; 1998 Jan; 14(2):109-15. PubMed ID: 9462920
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of HIV type 1 by alloimmune sera derived from polytransfused patients.
Spruth M; Stoiber H; Kacani L; Schönitzer D; Dierich MP
AIDS Res Hum Retroviruses; 1999 Apr; 15(6):533-43. PubMed ID: 10221530
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
Curtis BR; McFarland JG
Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of humoral immune response to donor HLA after implantation of cellularized versus decellularized human heart valve allografts.
Kneib C; von Glehn CQ; Costa FD; Costa MT; Susin MF
Tissue Antigens; 2012 Aug; 80(2):165-74. PubMed ID: 22631597
[TBL] [Abstract][Full Text] [Related]
6. Combining human antisera to human leukocyte antigens, HIVgp120 and 70 kDa heat shock protein results in broadly neutralizing activity to HIV-1.
Babaahmady K; Bergmeier LA; Lehner T
AIDS; 2008 Jul; 22(11):1267-76. PubMed ID: 18580605
[TBL] [Abstract][Full Text] [Related]
7. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
8. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
Sumitran-Karuppan S; Möller E
Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
[TBL] [Abstract][Full Text] [Related]
10. Detection of Antileukocytic Antibodies in Blood Serum using Lymphocytes and Latex Microspheres Carrying HLA-Antigens upon Alloimmunization of Women with Recurrent Pregnancy Loss.
Stepanova EO; Nikolaeva MA; Golubeva EL; Vtorushina VV; Van'ko LV; Khodzhaeva ZS; Krechetova LV
Bull Exp Biol Med; 2016 Mar; 160(5):722-6. PubMed ID: 27021079
[TBL] [Abstract][Full Text] [Related]
11. Methodological and clinical aspects of alloimmunization after granulocyte transfusion in patients undergoing allogeneic stem cell transplantation.
Flaxa J; Rosner A; Hölig K; Bornhäuser M; Wassmuth R
Tissue Antigens; 2015 Feb; 85(2):93-103. PubMed ID: 25515298
[TBL] [Abstract][Full Text] [Related]
12. Anti-HLA alloantibody is found in children but does not correlate with a lack of HIV type 1 transmission from infected mothers.
Luscher MA; Choy G; Embree JE; Nagelkerke NJ; Bwayo JJ; Njenga S; Plummer FA; Barber BH; MacDonald KS
AIDS Res Hum Retroviruses; 1998 Jan; 14(2):99-107. PubMed ID: 9462919
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates.
Arnold ML; Dechant M; Doxiadis II; Spriewald BM
Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575
[TBL] [Abstract][Full Text] [Related]
14. Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies.
Jaspan HB; Robinson JE; Amedee AM; Van Dyke RB; Garry RF
J Clin Virol; 2004 Nov; 31(3):190-7. PubMed ID: 15465411
[TBL] [Abstract][Full Text] [Related]
15. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
[TBL] [Abstract][Full Text] [Related]
16. Role of class-II major histocompatibility complex (MHC)-antigen-positive donor leukocytes in transfusion-induced alloimmunization to donor class-I MHC antigens.
Kao KJ; del Rosario ML
Blood; 1998 Jul; 92(2):690-4. PubMed ID: 9657772
[TBL] [Abstract][Full Text] [Related]
17. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
Shoker A; Klassen J; Herbut B
Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
[TBL] [Abstract][Full Text] [Related]
18. Complement-mediated enhancement of HIV-1 neutralisation by anti-HLA antibodies derived from polytransfused patients.
Wilfingseder D; Spruth M; Ammann CG; Döpper S; Speth C; Dierich MP; Stoiber H
Int Arch Allergy Immunol; 2003 May; 131(1):62-72. PubMed ID: 12759492
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies.
Hoekstra FM; Witvliet M; Knoop CY; Wassenaar C; Bogers AJ; Weimar W; Claas FH
Ann Thorac Surg; 1998 Dec; 66(6):2022-6. PubMed ID: 9930487
[TBL] [Abstract][Full Text] [Related]
20. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
Süsal C; Opelz G
Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
